These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 36438062)

  • 21. Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases.
    Elzayat H; Mesto G; Al-Marzooq F
    Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of infection in the aetiology of inflammatory bowel disease.
    Hansen R; Thomson JM; El-Omar EM; Hold GL
    J Gastroenterol; 2010 Mar; 45(3):266-76. PubMed ID: 20076977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Koch's postulates and infectious proteins.
    Walker L; Levine H; Jucker M
    Acta Neuropathol; 2006 Jul; 112(1):1-4. PubMed ID: 16703338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
    Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
    Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining dysbiosis threatens Koch's postulates and current dogma on the role of Paneth cells in Crohn's disease.
    Chamaillard M; Radulovic K
    Gut; 2016 Feb; 65(2):190-1. PubMed ID: 26268744
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel diseases: A review.
    Koutouratsas T; Philippou A; Kolios G; Koutsilieris M; Gazouli M
    World J Gastroenterol; 2021 Aug; 27(30):5037-5046. PubMed ID: 34497433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Koch's postulates: An interventionist perspective.
    Ross LN; Woodward JF
    Stud Hist Philos Biol Biomed Sci; 2016 Oct; 59():35-46. PubMed ID: 27315189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Koch's postulates applied to microbial pathogenicity.
    Falkow S
    Rev Infect Dis; 1988; 10 Suppl 2():S274-6. PubMed ID: 3055197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review.
    Axelrad JE; Cadwell KH; Colombel JF; Shah SC
    Therap Adv Gastroenterol; 2021; 14():17562848211004493. PubMed ID: 33868457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular commensalism: how oral corynebacteria and their extracellular membrane vesicles shape microbiome interactions.
    Kreth J; Helliwell E; Treerat P; Merritt J
    Front Oral Health; 2024; 5():1410786. PubMed ID: 38721621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commensal Koch's postulates: establishing causation in human microbiota research.
    Neville BA; Forster SC; Lawley TD
    Curr Opin Microbiol; 2018 Apr; 42():47-52. PubMed ID: 29112885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A matter of methods: the historicity of Koch's postulates 1840-2000].
    Gradmann C
    Medizinhist J; 2008; 43(2):121-48. PubMed ID: 18839931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease.
    Sultan S; El-Mowafy M; Elgaml A; Ahmed TAE; Hassan H; Mottawea W
    Front Physiol; 2021; 12():715506. PubMed ID: 34646151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
    Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
    World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
    Aldars-García L; Marin AC; Chaparro M; Gisbert JP
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysbiosis in the pathogenesis of pediatric inflammatory bowel diseases.
    Comito D; Romano C
    Int J Inflam; 2012; 2012():687143. PubMed ID: 22685684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.
    Santana PT; Rosas SLB; Ribeiro BE; Marinho Y; de Souza HSP
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.
    Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A
    Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysbiosis and Ecotypes of the Salivary Microbiome Associated With Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles.
    Xun Z; Zhang Q; Xu T; Chen N; Chen F
    Front Microbiol; 2018; 9():1136. PubMed ID: 29899737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.